NCT00942175 - A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants. | Biotech Hunter

Enrollment

160

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

July 31, 2010

Conditions

Healthy

Interventions

DRUG

Clopidogrel

Clopidogrel 75 mg, tablets, orally, once daily days 1-9.

DRUG

Clopidogrel and Lansoprazole

Clopidogrel 75 mg, tablets, orally, once daily and Lansoprazole 30 mg, capsules, orally, once daily days 1-9.

DRUG

Clopidogrel and Dexlansoprazole

Clopidogrel 75 mg, tablets, orally, once daily and Dexlansoprazole 60 mg, capsules, orally, once daily days 1-9.

DRUG

Clopidogrel and Omeprazole

Clopidogrel 75 mg, tablets, orally, once daily and Omeprazole 80 mg, capsules, orally, once daily days 1-9.

DRUG

Clopidogrel and Esomeprazole

Clopidogrel 75 mg, tablets, orally, once daily and Esomeprazole 40 mg, capsules, orally, once daily days 1-9.

Trial Locations (1)

Tempe